Filing Details

Accession Number:
0001144204-14-044298
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-22 21:26:52
Reporting Period:
2014-07-18
Filing Date:
2014-07-22
Accepted Time:
2014-07-22 21:26:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811240 Biolase Inc BIOL Dental Equipment & Supplies (3843) 870442441
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
926475 N Larry Feinberg 200 Greenwich Avenue
Greenwich CT 06830
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2014-07-18 369,044 $1.92 1,686,550 No 4 P Indirect See footnote
Common Stock, Par Value $0.001 Per Share Acquisiton 2014-07-18 1,641,036 $1.92 5,857,251 No 4 P Indirect See footnote
Common Stock, Par Value $0.001 Per Share Acquisiton 2014-07-18 260,756 $1.92 862,945 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. These securities are owned by Oracle Ten Fund Master, L.P. ("Ten Fund").
  2. These securities are owned by Oracle Partners, L.P. ("Partners").
  3. These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners").
  4. The Reporting Person serves as the managing member of Oracle Associates, LLC, the general partner of Partners and Institutional Partners, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners and Institutional Partners. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Ten Fund. Mr. Feinberg disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.
  5. On March 5, 2014, Biolase, Inc. declared a one-half percent stock dividend payable on March 28, 2014 to all stockholders of record on March 14, 2014. As a result, on March 28, 2014 Ten Fund received 6,554 shares of common stock, Partners received 20,976 shares of common stock, and Institutional Partners received 2,994 shares of common stock.